Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

Timothy Cardozo ¹, Ronald Veazey ²

Conclusions drawn from the study and clinical implications: The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials..